Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GLUKOS is a performance nutrition company that specializes in glucose-based energy products designed for rapid absorption and immediate fuel delivery. Founded by a former collegiate runner and sports medicine professional, the company's product line includes energy gels, powders, tablets, and gummies that utilize glucose as the primary carbohydrate source to mirror the body's natural fuel. Unlike many competitors that use fructose or sucrose, GLUKOS products aim to provide a faster energy spike without the gastrointestinal distress often associated with complex sugars. The company targets endurance athletes, professional sports teams, and individuals requiring rapid blood sugar management. Their formulations are marketed as being free from artificial colors, flavors, and sweeteners, emphasizing a clean-label approach to sports performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GLUKOS.